Immunoassay Market size is set to grow by USD 8.64 billion from 2024-2028, Predictive and preventive medicine for early diagnosis and treatment boost the market, Technavio

NEW YORK, May 23, 2024 /PRNewswire/ -- The global immunoassay market  size is estimated to grow by USD 8.64 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  4.42%  during the forecast period. 

For more insights on the forecast market size and historic data (2018 - 2022) - Buy Report

Market Driver

Immunoassays represent a significant segment of diagnostic testing in medical technology, utilizing laboratory equipment for biomarker detection through antibody-based assays. These analytical methods offer high sensitivity for infectious disease testing, cancer biomarkers, autoimmune disease testing, and therapeutic drug monitoring. Immunosuppressant assays and precision medicine applications also contribute to the market's growth.

Immunoassay platforms include various techniques such as fluorescence immunoassays, chemiluminescent immunoassays, and radioimmunoassays, among others. Clinical and research laboratories employ these assays for assay development, validation, optimization, and biomarker discovery. Immunoassay performance is crucial, ensuring accuracy, precision, sensitivity, and specificity. 

Market Challenges

• Immunoassays are complex analytical techniques used extensively in clinical and research laboratories for protein detection, hormone assays, infectious disease testing, and autoimmune disease diagnosis, among others. Key technologies include lateral flow assays, immunofluorescence assays, multiplex assays, and immunoassay kits.
• Diagnostic reagents, biosensors, microfluidic devices, and immunosuppressant assays are essential components. Immunoassay platforms, precision medicine, and assay development are advancing the field, while clinical and research laboratories rely on immunoassay optimization, validation, and automation for improved performance, accuracy, and reliability. Immunoassay sensitivity and specificity are crucial factors in achieving successful results.

Research report provides comprehensive data on impact of trend, driver and challenges - Request a sample report!

Segment Overview 

1. Product 
• 1.1 Reagents and kits
• 1.2 Analyzers
2. Technology 
• 2.1 ELISA
• 2.2 Radioimmunoassay (RIA)
• 2.3 ELISpot and others
3. Geography 
• 3.1 North America
• 3.2 Europe
• 3.3 Asia
• 3.4 Rest of World (ROW)

1.1 Reagents and kits-  In the Immunoassay market, product segmentation revolves around various types of diagnostic reagents and associated technologies. These reagents significantly enhance immunoassay reliability, a crucial aspect of medical technology and clinical diagnostics. Immunoassays encompass diagnostic testing using laboratory equipment and analytical methods, with applications in biomarker detection, antibody-based assays, and infectious disease testing.

The market comprises diverse assay formats, including fluorescence immunoassays, chemiluminescent immunoassays, radioimmunoassays, lateral flow assays, immunofluorescence assays, and multiplex assays. Immunoassay kits and diagnostic reagents are essential components, catering to various clinical needs such as hormone assays, cancer biomarkers, autoimmune disease testing, allergy testing, therapeutic drug monitoring, and immunosuppressant assays.

Biosensors and microfluidic devices are emerging technologies that improve assay performance and manufacturability by maintaining protein activity and longer shelf life. These advancements contribute to the development of point-of-care testing, rapid diagnostic tests, and clinical applications in immunochemistry. The compatibility of reagent formulations with analyzer materials is essential to prevent any damage to the analyzer components.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) - Download a Sample Report

Research Analysis

The Immunoassay market encompasses a range of diagnostic testing technologies in the medical technology sector. Laboratories utilize immunodiagnostic assays for biomarker detection, including antibody-based assays, which employ analytical methods for clinical diagnostics. Point-of-care testing has gained popularity with the advent of rapid diagnostic tests, such as fluorescence immunoassays, chemiluminescent immunoassays, and radioimmunoassays.

Lateral flow assays, immunofluorescence assays, and multiplex assays are other immunochemical techniques used for protein detection, hormone assays, infectious disease testing, cancer biomarkers, autoimmune disease testing, allergy testing, therapeutic drug monitoring, and immunosuppressant assays. Immunoassay kits and diagnostic reagents are essential components, while biosensors and microfluidic devices facilitate automation and miniaturization.

Market Research Overview

The Immunoassay market refers to a diagnostic technique used to identify and measure the presence and quantity of antigens, antibodies, or other proteins in various samples. This market encompasses a range of applications, including clinical diagnostics, research and development, and quality control in industries. Immunoassays offer advantages such as high sensitivity, specificity, and ease of use, making them a preferred choice for disease screening, drug discovery, and food analysis.

Technologies within this market include ELISA, Western blot, and chemiluminescence immunoassay, among others. The global Immunoassay market is expected to grow significantly due to increasing demand for accurate and rapid diagnostic tests, advancements in technology, and expanding applications in various industries.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Product
• Reagents And Kits
• Analyzers
• Technology
• ELISA
• Radioimmunoassay (RIA)
• ELISpot And Others
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio